Stock Analysis

A Closer Look at Align Technology (ALGN) Valuation Following Recent Share Price Momentum

Align Technology (ALGN) shares have drawn attention after the stock posted a 3% gain over the past week, continuing an upward trend for the month. Investors are watching closely as the broader healthcare sector shows mixed signals.

See our latest analysis for Align Technology.

Zooming out, Align Technology’s 1-month share price return of 9.1% reflects a noticeable turnaround, even as its total shareholder return over the past year remains down more than 35%. After months of fading momentum, this stronger weekly move has some investors speculating about renewed interest, growth potential, or even an improvement in risk sentiment.

If Align’s recent shift caught your attention, consider exploring other innovative healthcare stocks making waves, such as those found in See the full list for free.

Given Align Technology’s recent uptick and its stock still trading well below analyst price targets, is this renewed momentum signaling an undervalued opportunity, or have market expectations for future growth already been factored in?

Advertisement

Most Popular Narrative: 18.3% Undervalued

With Align Technology’s most-watched narrative assigning a fair value of $180.50, the latest closing price of $147.50 leaves a considerable gap. This has captured attention from bargain hunters and skeptics alike.

The continued expansion of clinical indications for Invisalign (such as Invisalign First for teens/kids and palate expanders) and the increasing adoption by general practitioner dentists are broadening Align's addressable market. This is positioning the company for higher long-term revenues and double-digit earnings growth as these new segments mature.

Read the complete narrative.

What are the core numbers and bold projections driving this steep discount? The secret is a mix of rising profitability and expanding markets that analysts believe could reshape the company's earnings power. Unlock the full story to see which key assumptions the narrative is built on and why this valuation stands out.

Result: Fair Value of $180.50 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, ongoing macroeconomic uncertainty or a shift in patient preferences toward traditional braces could quickly reverse Align Technology's upbeat projections.

Find out about the key risks to this Align Technology narrative.

Build Your Own Align Technology Narrative

Keep in mind, if you have a different take or want to dive into the details yourself, crafting your own perspective takes less than three minutes, and you can Do it your way.

A good starting point is our analysis highlighting 4 key rewards investors are optimistic about regarding Align Technology.

Looking for More Investment Ideas?

Sharpen your strategy and get ahead. Don’t let unique growth or value opportunities pass you by. These standouts are making headlines for a reason:

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqGS:ALGN

Align Technology

Provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally.

Very undervalued with flawless balance sheet.

Advertisement

Updated Narratives

BE
Bejgal
MNSO logo
Bejgal on MINISO Group Holding ·

MINISO's fair value is projected at 26.69 with an anticipated PE ratio shift of 20x

Fair Value:US$26.6928.0% undervalued
44 users have followed this narrative
3 users have commented on this narrative
0 users have liked this narrative
TI
TickerTickle
ORCL logo
TickerTickle on Oracle ·

The Quiet Giant That Became AI’s Power Grid

Fair Value:US$389.8149.5% undervalued
7 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative
AU
AuCA
NLBR logo
AuCA on Nova Ljubljanska Banka d.d ·

Nova Ljubljanska Banka d.d will expect a 11.2% revenue boost driving future growth

Fair Value:€20916.3% undervalued
23 users have followed this narrative
3 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
GOOGL logo
oscargarcia on Alphabet ·

The company that turned a verb into a global necessity and basically runs the modern internet, digital ads, smartphones, maps, and AI.

Fair Value:US$3404.9% undervalued
134 users have followed this narrative
6 users have commented on this narrative
18 users have liked this narrative
TH
TheWallstreetKing
MVIS logo
TheWallstreetKing on MicroVision ·

MicroVision will explode future revenue by 380.37% with a vision towards success

Fair Value:US$6098.4% undervalued
83 users have followed this narrative
11 users have commented on this narrative
18 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$232.7923.6% undervalued
923 users have followed this narrative
5 users have commented on this narrative
22 users have liked this narrative